Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Endosonography | 24 | 2023 | 626 | 4.060 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 19 | 2023 | 520 | 3.290 |
Why?
|
Colonoscopy | 29 | 2023 | 1409 | 3.040 |
Why?
|
Pancreatic Neoplasms | 23 | 2024 | 5444 | 2.460 |
Why?
|
Endoscopy, Gastrointestinal | 23 | 2022 | 889 | 2.400 |
Why?
|
Carcinoma, Pancreatic Ductal | 8 | 2024 | 1757 | 1.600 |
Why?
|
Duodenoscopes | 5 | 2020 | 43 | 1.490 |
Why?
|
Colonic Polyps | 10 | 2023 | 557 | 1.430 |
Why?
|
Neoplasms, Cystic, Mucinous, and Serous | 3 | 2023 | 195 | 1.420 |
Why?
|
Equipment Contamination | 5 | 2021 | 183 | 1.380 |
Why?
|
Adenoma | 9 | 2022 | 2155 | 1.150 |
Why?
|
Disinfection | 4 | 2021 | 207 | 1.100 |
Why?
|
Equipment Reuse | 4 | 2021 | 45 | 0.940 |
Why?
|
Cholangitis | 2 | 2021 | 110 | 0.860 |
Why?
|
Quality Indicators, Health Care | 11 | 2015 | 1804 | 0.820 |
Why?
|
Pancreatitis, Chronic | 5 | 2020 | 282 | 0.820 |
Why?
|
Pancreas | 7 | 2023 | 1698 | 0.690 |
Why?
|
BRCA2 Protein | 3 | 2023 | 802 | 0.680 |
Why?
|
Endoscopy, Digestive System | 7 | 2023 | 358 | 0.670 |
Why?
|
Colon | 4 | 2023 | 1797 | 0.670 |
Why?
|
Choledocholithiasis | 3 | 2019 | 50 | 0.660 |
Why?
|
Early Detection of Cancer | 8 | 2024 | 3235 | 0.630 |
Why?
|
Cross Infection | 2 | 2019 | 1427 | 0.630 |
Why?
|
Colorectal Neoplasms | 12 | 2022 | 6965 | 0.620 |
Why?
|
Bile | 2 | 2013 | 300 | 0.620 |
Why?
|
Cholecystectomy | 3 | 2019 | 409 | 0.600 |
Why?
|
Gastrointestinal Diseases | 3 | 2021 | 1203 | 0.590 |
Why?
|
o-Phthalaldehyde | 1 | 2017 | 15 | 0.580 |
Why?
|
Duodenoscopy | 1 | 2017 | 45 | 0.580 |
Why?
|
Ethylene Oxide | 1 | 2017 | 28 | 0.580 |
Why?
|
Cysts | 1 | 2023 | 685 | 0.570 |
Why?
|
Pancreatitis | 5 | 2017 | 1087 | 0.570 |
Why?
|
Colonic Neoplasms | 5 | 2015 | 2535 | 0.570 |
Why?
|
Pancreatic Diseases | 4 | 2017 | 353 | 0.560 |
Why?
|
Esophageal Neoplasms | 4 | 2016 | 1661 | 0.550 |
Why?
|
Elasticity Imaging Techniques | 1 | 2021 | 398 | 0.540 |
Why?
|
Sterilization | 1 | 2017 | 132 | 0.530 |
Why?
|
Barrett Esophagus | 5 | 2022 | 494 | 0.520 |
Why?
|
Disinfectants | 1 | 2017 | 131 | 0.510 |
Why?
|
Isotonic Solutions | 1 | 2016 | 119 | 0.510 |
Why?
|
Occult Blood | 2 | 2010 | 199 | 0.500 |
Why?
|
Pancreatic Cyst | 2 | 2009 | 372 | 0.480 |
Why?
|
Cholestasis | 3 | 2023 | 385 | 0.450 |
Why?
|
Gastrointestinal Hemorrhage | 6 | 2019 | 1126 | 0.450 |
Why?
|
Bile Duct Neoplasms | 5 | 2023 | 614 | 0.450 |
Why?
|
Conscious Sedation | 3 | 2016 | 534 | 0.440 |
Why?
|
Fiducial Markers | 2 | 2021 | 134 | 0.430 |
Why?
|
Triage | 1 | 2020 | 995 | 0.420 |
Why?
|
Secretin | 3 | 2020 | 57 | 0.420 |
Why?
|
Vena Cava, Inferior | 2 | 2019 | 463 | 0.410 |
Why?
|
Adenocarcinoma | 6 | 2019 | 6359 | 0.410 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2017 | 592 | 0.410 |
Why?
|
DNA, Neoplasm | 2 | 2009 | 1741 | 0.400 |
Why?
|
Postoperative Hemorrhage | 3 | 2023 | 418 | 0.390 |
Why?
|
Practice Guidelines as Topic | 7 | 2020 | 7430 | 0.390 |
Why?
|
Endoscopes | 3 | 2022 | 169 | 0.390 |
Why?
|
Anesthetics, Intravenous | 2 | 2014 | 396 | 0.380 |
Why?
|
Humans | 130 | 2024 | 766812 | 0.380 |
Why?
|
Carcinoma in Situ | 1 | 2017 | 784 | 0.380 |
Why?
|
Anastomotic Leak | 1 | 2013 | 170 | 0.370 |
Why?
|
Middle Aged | 61 | 2024 | 223267 | 0.370 |
Why?
|
Deep Sedation | 3 | 2020 | 119 | 0.370 |
Why?
|
Rectal Diseases | 3 | 2019 | 141 | 0.360 |
Why?
|
Pancreatic Ducts | 3 | 2023 | 330 | 0.350 |
Why?
|
Propofol | 2 | 2013 | 608 | 0.350 |
Why?
|
Esophagogastric Junction | 1 | 2012 | 350 | 0.340 |
Why?
|
Stomach Neoplasms | 2 | 2020 | 1480 | 0.340 |
Why?
|
Antibiotic Prophylaxis | 1 | 2015 | 641 | 0.330 |
Why?
|
Consensus | 2 | 2020 | 3208 | 0.330 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 3 | 2020 | 100 | 0.330 |
Why?
|
Hypnotics and Sedatives | 2 | 2016 | 1193 | 0.320 |
Why?
|
Male | 69 | 2024 | 364154 | 0.310 |
Why?
|
Aspirin | 3 | 2017 | 3134 | 0.310 |
Why?
|
Bile Ducts | 4 | 2023 | 288 | 0.300 |
Why?
|
Prospective Studies | 22 | 2023 | 54872 | 0.300 |
Why?
|
Female | 66 | 2024 | 396532 | 0.300 |
Why?
|
Attitude of Health Personnel | 2 | 2020 | 3927 | 0.290 |
Why?
|
Carcinoembryonic Antigen | 1 | 2009 | 338 | 0.290 |
Why?
|
Internal Medicine | 1 | 2015 | 1064 | 0.290 |
Why?
|
Hemostasis, Endoscopic | 1 | 2008 | 42 | 0.290 |
Why?
|
Retrospective Studies | 36 | 2023 | 81657 | 0.280 |
Why?
|
Microsatellite Instability | 2 | 2009 | 726 | 0.270 |
Why?
|
Aged | 49 | 2024 | 171344 | 0.270 |
Why?
|
Predictive Value of Tests | 13 | 2021 | 15425 | 0.270 |
Why?
|
BRCA1 Protein | 2 | 2023 | 1155 | 0.260 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3110 | 0.250 |
Why?
|
Biopsy, Fine-Needle | 5 | 2009 | 1131 | 0.250 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3232 | 0.250 |
Why?
|
Biliary Tract Diseases | 2 | 2017 | 159 | 0.250 |
Why?
|
Pancreatic Function Tests | 2 | 2017 | 69 | 0.250 |
Why?
|
Hemodynamics | 1 | 2016 | 4188 | 0.250 |
Why?
|
Ticlopidine | 1 | 2010 | 729 | 0.250 |
Why?
|
Antiemetics | 1 | 2006 | 187 | 0.240 |
Why?
|
Lymph Nodes | 2 | 2007 | 3468 | 0.240 |
Why?
|
Genetic Predisposition to Disease | 4 | 2022 | 18076 | 0.240 |
Why?
|
Cecal Diseases | 1 | 2004 | 49 | 0.240 |
Why?
|
Osteitis Deformans | 1 | 2004 | 54 | 0.240 |
Why?
|
Antidepressive Agents, Tricyclic | 1 | 2006 | 427 | 0.240 |
Why?
|
Colonic Diseases | 2 | 2014 | 204 | 0.240 |
Why?
|
Stents | 5 | 2021 | 3193 | 0.230 |
Why?
|
Odds Ratio | 7 | 2016 | 9661 | 0.230 |
Why?
|
Mediastinal Neoplasms | 1 | 2007 | 403 | 0.230 |
Why?
|
Patient Satisfaction | 3 | 2014 | 3485 | 0.230 |
Why?
|
Aged, 80 and over | 26 | 2021 | 59548 | 0.220 |
Why?
|
Academic Medical Centers | 3 | 2019 | 2783 | 0.220 |
Why?
|
Ferritins | 1 | 2006 | 601 | 0.220 |
Why?
|
Bile Duct Diseases | 3 | 2014 | 98 | 0.220 |
Why?
|
DNA Mismatch Repair | 1 | 2006 | 431 | 0.220 |
Why?
|
Alendronate | 1 | 2004 | 174 | 0.220 |
Why?
|
Anesthetics | 2 | 2023 | 525 | 0.220 |
Why?
|
Vomiting | 1 | 2006 | 652 | 0.210 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2017 | 2763 | 0.210 |
Why?
|
Clinical Competence | 4 | 2018 | 4858 | 0.210 |
Why?
|
Esophagoscopy | 3 | 2016 | 398 | 0.210 |
Why?
|
Cystadenocarcinoma, Mucinous | 2 | 2016 | 51 | 0.210 |
Why?
|
Anesthesia, General | 3 | 2023 | 1188 | 0.210 |
Why?
|
Cystadenoma, Mucinous | 2 | 2016 | 62 | 0.210 |
Why?
|
Time Factors | 14 | 2022 | 40149 | 0.200 |
Why?
|
Patient Selection | 3 | 2024 | 4252 | 0.200 |
Why?
|
Lymphatic Metastasis | 2 | 2007 | 2901 | 0.200 |
Why?
|
Arrhythmias, Cardiac | 2 | 2014 | 2257 | 0.200 |
Why?
|
Lung Neoplasms | 4 | 2007 | 13489 | 0.200 |
Why?
|
Sphincterotomy, Endoscopic | 2 | 2019 | 44 | 0.190 |
Why?
|
Incidence | 7 | 2023 | 21527 | 0.190 |
Why?
|
Biopsy | 7 | 2022 | 6779 | 0.190 |
Why?
|
Gastroenterology | 2 | 2021 | 593 | 0.190 |
Why?
|
Warfarin | 1 | 2010 | 1493 | 0.190 |
Why?
|
Risk Assessment | 9 | 2021 | 24299 | 0.190 |
Why?
|
Carcinoma | 3 | 2020 | 2325 | 0.180 |
Why?
|
Emergencies | 2 | 2021 | 1223 | 0.180 |
Why?
|
Liver Transplantation | 1 | 2013 | 2416 | 0.180 |
Why?
|
Sensitivity and Specificity | 9 | 2020 | 14653 | 0.180 |
Why?
|
Mass Screening | 2 | 2022 | 5454 | 0.180 |
Why?
|
Gastric Outlet Obstruction | 1 | 2020 | 55 | 0.180 |
Why?
|
Cholangiocarcinoma | 2 | 2023 | 562 | 0.180 |
Why?
|
Liver Cirrhosis | 3 | 2021 | 1960 | 0.170 |
Why?
|
Colonic Pseudo-Obstruction | 1 | 2019 | 7 | 0.170 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2010 | 2056 | 0.170 |
Why?
|
Esophageal Sphincter, Lower | 1 | 2019 | 26 | 0.170 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2010 | 2270 | 0.170 |
Why?
|
Drainage | 3 | 2021 | 1182 | 0.170 |
Why?
|
Thyroid Gland | 1 | 2006 | 1170 | 0.170 |
Why?
|
Scattering, Radiation | 1 | 2021 | 483 | 0.160 |
Why?
|
Proctoscopy | 1 | 2019 | 40 | 0.160 |
Why?
|
Reproducibility of Results | 10 | 2017 | 20146 | 0.160 |
Why?
|
Quality Improvement | 1 | 2015 | 3850 | 0.160 |
Why?
|
Sigmoid Diseases | 1 | 2019 | 61 | 0.160 |
Why?
|
Severity of Illness Index | 7 | 2020 | 15912 | 0.160 |
Why?
|
Physicians | 2 | 2015 | 4591 | 0.160 |
Why?
|
Pancreatic Pseudocyst | 1 | 2019 | 112 | 0.160 |
Why?
|
Intestinal Volvulus | 1 | 2019 | 82 | 0.160 |
Why?
|
Feedback | 1 | 2022 | 797 | 0.150 |
Why?
|
Esophageal Achalasia | 1 | 2019 | 99 | 0.150 |
Why?
|
Adenocarcinoma, Mucinous | 2 | 2016 | 523 | 0.150 |
Why?
|
Constriction, Pathologic | 3 | 2023 | 1104 | 0.150 |
Why?
|
Adenomatous Polyposis Coli | 1 | 2020 | 219 | 0.150 |
Why?
|
Dilatation | 1 | 2019 | 311 | 0.150 |
Why?
|
Botulinum Toxins | 1 | 2019 | 191 | 0.150 |
Why?
|
Cholinesterase Inhibitors | 1 | 2019 | 242 | 0.150 |
Why?
|
Organoids | 2 | 2022 | 740 | 0.150 |
Why?
|
Radiosurgery | 3 | 2013 | 1330 | 0.150 |
Why?
|
Sex Factors | 3 | 2024 | 10619 | 0.140 |
Why?
|
Task Performance and Analysis | 2 | 2019 | 771 | 0.140 |
Why?
|
Fiber Optic Technology | 2 | 2017 | 290 | 0.140 |
Why?
|
Acute Disease | 4 | 2021 | 7240 | 0.140 |
Why?
|
Pancreatic Juice | 1 | 2017 | 60 | 0.140 |
Why?
|
Ultrasonography, Interventional | 3 | 2019 | 1521 | 0.140 |
Why?
|
Rectum | 2 | 2019 | 897 | 0.140 |
Why?
|
Adult | 30 | 2022 | 223305 | 0.140 |
Why?
|
Endoscopy | 3 | 2022 | 1854 | 0.140 |
Why?
|
Logistic Models | 6 | 2019 | 13276 | 0.140 |
Why?
|
Bacteria | 2 | 2019 | 2212 | 0.140 |
Why?
|
Anemia | 1 | 2006 | 1514 | 0.140 |
Why?
|
Diagnosis, Differential | 6 | 2015 | 12985 | 0.140 |
Why?
|
Follow-Up Studies | 10 | 2015 | 39312 | 0.140 |
Why?
|
Microscopy, Confocal | 2 | 2013 | 1969 | 0.140 |
Why?
|
Gases | 1 | 2017 | 205 | 0.130 |
Why?
|
Neoplasm Staging | 4 | 2011 | 11218 | 0.130 |
Why?
|
Age Factors | 4 | 2024 | 18397 | 0.130 |
Why?
|
Education | 1 | 2019 | 531 | 0.130 |
Why?
|
Bacteriological Techniques | 1 | 2017 | 277 | 0.130 |
Why?
|
Ampulla of Vater | 2 | 2014 | 150 | 0.130 |
Why?
|
Delphi Technique | 1 | 2020 | 892 | 0.130 |
Why?
|
Deoxycytidine | 2 | 2011 | 886 | 0.130 |
Why?
|
Swine | 3 | 2022 | 5985 | 0.130 |
Why?
|
Hemorrhage | 2 | 2019 | 3464 | 0.120 |
Why?
|
Cryotherapy | 1 | 2016 | 164 | 0.120 |
Why?
|
Postoperative Complications | 5 | 2019 | 15831 | 0.120 |
Why?
|
Cystadenoma, Serous | 1 | 2016 | 99 | 0.120 |
Why?
|
Prediabetic State | 1 | 2021 | 547 | 0.120 |
Why?
|
Antidotes | 1 | 2016 | 138 | 0.120 |
Why?
|
Mediastinum | 2 | 2007 | 272 | 0.120 |
Why?
|
Gastrointestinal Agents | 1 | 2020 | 511 | 0.120 |
Why?
|
Jaundice, Obstructive | 1 | 2014 | 22 | 0.120 |
Why?
|
Liver | 2 | 2021 | 7571 | 0.120 |
Why?
|
Gastroscopy | 1 | 2016 | 213 | 0.120 |
Why?
|
Lipase | 1 | 2017 | 320 | 0.120 |
Why?
|
Algorithms | 1 | 2015 | 14073 | 0.120 |
Why?
|
Cholangiography | 1 | 2014 | 182 | 0.120 |
Why?
|
Decompression, Surgical | 1 | 2019 | 603 | 0.120 |
Why?
|
Mutation | 2 | 2017 | 30214 | 0.120 |
Why?
|
Fibrosis | 1 | 2021 | 2078 | 0.120 |
Why?
|
Duodenal Diseases | 1 | 2014 | 101 | 0.110 |
Why?
|
Catheter Ablation | 3 | 2016 | 2787 | 0.110 |
Why?
|
Anticoagulants | 1 | 2010 | 4854 | 0.110 |
Why?
|
Treatment Outcome | 11 | 2022 | 65286 | 0.110 |
Why?
|
Prevalence | 3 | 2023 | 15835 | 0.110 |
Why?
|
Common Bile Duct | 1 | 2014 | 106 | 0.110 |
Why?
|
Communicable Diseases | 1 | 2022 | 872 | 0.110 |
Why?
|
Esophageal Diseases | 1 | 2014 | 167 | 0.110 |
Why?
|
Dissection | 2 | 2018 | 298 | 0.110 |
Why?
|
Peritonitis | 1 | 2016 | 368 | 0.110 |
Why?
|
Proteomics | 2 | 2024 | 3915 | 0.110 |
Why?
|
Advisory Committees | 5 | 2014 | 797 | 0.110 |
Why?
|
Stomach Diseases | 1 | 2014 | 134 | 0.110 |
Why?
|
Diagnostic Imaging | 4 | 2016 | 3530 | 0.110 |
Why?
|
Propensity Score | 1 | 2021 | 1972 | 0.110 |
Why?
|
Abdominal Pain | 1 | 2019 | 1069 | 0.110 |
Why?
|
Thyroid Neoplasms | 1 | 2006 | 2355 | 0.110 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2020 | 4056 | 0.100 |
Why?
|
Multivariate Analysis | 5 | 2019 | 12064 | 0.100 |
Why?
|
Emergency Service, Hospital | 3 | 2019 | 7870 | 0.100 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2010 | 4628 | 0.100 |
Why?
|
Bronchoscopes | 1 | 2012 | 64 | 0.100 |
Why?
|
Dilatation, Pathologic | 2 | 2014 | 527 | 0.100 |
Why?
|
Family Practice | 1 | 2015 | 508 | 0.100 |
Why?
|
Cystic Duct | 1 | 2011 | 18 | 0.100 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2006 | 3446 | 0.100 |
Why?
|
Cecum | 2 | 2019 | 231 | 0.100 |
Why?
|
Radiation Injuries | 1 | 2019 | 1195 | 0.100 |
Why?
|
Risk Factors | 13 | 2021 | 74889 | 0.100 |
Why?
|
Young Adult | 10 | 2020 | 59939 | 0.090 |
Why?
|
Narcotic Antagonists | 1 | 2016 | 591 | 0.090 |
Why?
|
Cohort Studies | 7 | 2021 | 41706 | 0.090 |
Why?
|
Occupational Exposure | 1 | 2021 | 1807 | 0.090 |
Why?
|
Hypertension | 1 | 2011 | 8616 | 0.090 |
Why?
|
Adenosine Triphosphate | 1 | 2017 | 2001 | 0.090 |
Why?
|
Depression | 1 | 2010 | 8225 | 0.090 |
Why?
|
Gastroscopes | 1 | 2010 | 20 | 0.090 |
Why?
|
Palliative Care | 3 | 2021 | 3640 | 0.090 |
Why?
|
Geriatrics | 1 | 2015 | 394 | 0.090 |
Why?
|
Case-Control Studies | 6 | 2016 | 22248 | 0.090 |
Why?
|
Echocardiography, Transesophageal | 1 | 2016 | 1093 | 0.090 |
Why?
|
Heterozygote | 1 | 2017 | 2795 | 0.090 |
Why?
|
Pandemics | 2 | 2020 | 8734 | 0.090 |
Why?
|
Anesthesia Recovery Period | 1 | 2011 | 155 | 0.090 |
Why?
|
Length of Stay | 2 | 2021 | 6491 | 0.090 |
Why?
|
Primary Prevention | 1 | 2017 | 1188 | 0.090 |
Why?
|
Cryosurgery | 1 | 2015 | 479 | 0.080 |
Why?
|
Heart Diseases | 1 | 2003 | 2817 | 0.080 |
Why?
|
Device Removal | 1 | 2015 | 643 | 0.080 |
Why?
|
Positron-Emission Tomography | 1 | 2006 | 6548 | 0.080 |
Why?
|
Tomography, X-Ray Computed | 5 | 2016 | 20710 | 0.080 |
Why?
|
Nursing Staff | 1 | 2010 | 113 | 0.080 |
Why?
|
Observer Variation | 2 | 2013 | 2614 | 0.080 |
Why?
|
Oxygen | 1 | 2021 | 4252 | 0.080 |
Why?
|
Endoscopes, Gastrointestinal | 2 | 2021 | 45 | 0.080 |
Why?
|
Tumor Burden | 1 | 2015 | 1902 | 0.080 |
Why?
|
Catheterization | 1 | 2014 | 1429 | 0.080 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2011 | 348 | 0.080 |
Why?
|
Gallstones | 1 | 2011 | 285 | 0.080 |
Why?
|
Microscopy, Polarization | 1 | 2009 | 88 | 0.080 |
Why?
|
Allelic Imbalance | 1 | 2009 | 77 | 0.080 |
Why?
|
Pneumonia | 1 | 2020 | 2161 | 0.080 |
Why?
|
Cyst Fluid | 1 | 2009 | 86 | 0.080 |
Why?
|
Intubation, Intratracheal | 2 | 2014 | 1359 | 0.080 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2007 | 5389 | 0.080 |
Why?
|
Syndrome | 1 | 2015 | 3271 | 0.080 |
Why?
|
Salvage Therapy | 1 | 2015 | 1274 | 0.080 |
Why?
|
Biomedical Research | 1 | 2024 | 3459 | 0.080 |
Why?
|
Biopsy, Needle | 3 | 2009 | 1615 | 0.080 |
Why?
|
Healthcare Disparities | 1 | 2024 | 3411 | 0.070 |
Why?
|
Histocytochemistry | 1 | 2009 | 697 | 0.070 |
Why?
|
Probability | 3 | 2009 | 2476 | 0.070 |
Why?
|
Mediastinoscopy | 1 | 2007 | 29 | 0.070 |
Why?
|
Lung | 1 | 2006 | 10068 | 0.070 |
Why?
|
Monitoring, Intraoperative | 1 | 2014 | 947 | 0.070 |
Why?
|
Confidence Intervals | 2 | 2009 | 2921 | 0.070 |
Why?
|
Gastric Mucosa | 1 | 2010 | 602 | 0.070 |
Why?
|
Remission Induction | 1 | 2013 | 2413 | 0.070 |
Why?
|
Referral and Consultation | 1 | 2020 | 3618 | 0.070 |
Why?
|
Massachusetts | 2 | 2011 | 8890 | 0.070 |
Why?
|
Blood Glucose | 1 | 2021 | 6422 | 0.070 |
Why?
|
Terminology as Topic | 1 | 2014 | 1540 | 0.070 |
Why?
|
Unnecessary Procedures | 1 | 2010 | 412 | 0.070 |
Why?
|
Deglutition Disorders | 1 | 2012 | 640 | 0.070 |
Why?
|
Tomography, Optical Coherence | 1 | 2019 | 2954 | 0.070 |
Why?
|
Hyperlipidemias | 1 | 2011 | 771 | 0.060 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2010 | 646 | 0.060 |
Why?
|
Health Personnel | 1 | 2020 | 3384 | 0.060 |
Why?
|
Databases, Factual | 4 | 2017 | 8065 | 0.060 |
Why?
|
Hospitalization | 2 | 2019 | 10816 | 0.060 |
Why?
|
Intestinal Mucosa | 1 | 2017 | 3041 | 0.060 |
Why?
|
Stomach | 1 | 2010 | 701 | 0.060 |
Why?
|
Chronic Disease | 4 | 2021 | 9358 | 0.060 |
Why?
|
Chromosome Banding | 1 | 2005 | 261 | 0.060 |
Why?
|
Education, Medical, Undergraduate | 1 | 2015 | 1087 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 3 | 2019 | 6514 | 0.060 |
Why?
|
Spectrum Analysis | 2 | 2023 | 443 | 0.060 |
Why?
|
Prognosis | 4 | 2020 | 29959 | 0.060 |
Why?
|
Thoracotomy | 1 | 2007 | 374 | 0.060 |
Why?
|
CpG Islands | 1 | 2009 | 1208 | 0.060 |
Why?
|
Anesthesia | 1 | 2016 | 1595 | 0.060 |
Why?
|
Fatty Liver | 1 | 2011 | 810 | 0.060 |
Why?
|
Genetic Testing | 3 | 2020 | 3591 | 0.060 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2005 | 348 | 0.060 |
Why?
|
Hospital Costs | 1 | 2010 | 955 | 0.060 |
Why?
|
Guideline Adherence | 1 | 2015 | 2233 | 0.060 |
Why?
|
Education, Medical, Continuing | 1 | 2009 | 830 | 0.060 |
Why?
|
United States | 10 | 2022 | 72945 | 0.060 |
Why?
|
Critical Illness | 1 | 2017 | 2750 | 0.060 |
Why?
|
Nausea | 1 | 2006 | 681 | 0.050 |
Why?
|
Models, Animal | 1 | 2010 | 2121 | 0.050 |
Why?
|
Point Mutation | 1 | 2009 | 1592 | 0.050 |
Why?
|
ras Proteins | 1 | 2009 | 1055 | 0.050 |
Why?
|
Colitis, Ischemic | 1 | 2003 | 32 | 0.050 |
Why?
|
Societies, Medical | 3 | 2020 | 3957 | 0.050 |
Why?
|
Heart | 1 | 2016 | 4425 | 0.050 |
Why?
|
2-Pyridinylmethylsulfinylbenzimidazoles | 1 | 2003 | 31 | 0.050 |
Why?
|
Reference Values | 2 | 2008 | 4914 | 0.050 |
Why?
|
Likelihood Functions | 1 | 2006 | 993 | 0.050 |
Why?
|
Health Status | 1 | 2016 | 4087 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2021 | 5888 | 0.050 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2006 | 12246 | 0.050 |
Why?
|
Outpatients | 1 | 2010 | 1596 | 0.050 |
Why?
|
Omeprazole | 1 | 2003 | 106 | 0.050 |
Why?
|
Enterocolitis | 1 | 2003 | 106 | 0.050 |
Why?
|
Anti-Ulcer Agents | 1 | 2003 | 112 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2020 | 8623 | 0.050 |
Why?
|
Patients | 2 | 2023 | 908 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 4 | 2019 | 36570 | 0.050 |
Why?
|
Ulcer | 1 | 2003 | 203 | 0.050 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2023 | 303 | 0.050 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18329 | 0.050 |
Why?
|
Adolescent | 6 | 2020 | 88902 | 0.050 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2009 | 1762 | 0.050 |
Why?
|
Chromosome Deletion | 1 | 2005 | 1384 | 0.040 |
Why?
|
Lactulose | 1 | 2000 | 30 | 0.040 |
Why?
|
CA-19-9 Antigen | 2 | 2011 | 109 | 0.040 |
Why?
|
Equipment Design | 3 | 2017 | 3488 | 0.040 |
Why?
|
Health Surveys | 1 | 2010 | 4055 | 0.040 |
Why?
|
Surgical Instruments | 1 | 2023 | 379 | 0.040 |
Why?
|
Chi-Square Distribution | 1 | 2006 | 3431 | 0.040 |
Why?
|
Bronchoscopy | 1 | 2006 | 913 | 0.040 |
Why?
|
Clinical Laboratory Techniques | 1 | 2005 | 746 | 0.040 |
Why?
|
Drug Administration Schedule | 2 | 2011 | 4853 | 0.040 |
Why?
|
Blood Pressure | 1 | 2016 | 8533 | 0.040 |
Why?
|
Neostigmine | 1 | 2019 | 68 | 0.040 |
Why?
|
Psychology, Educational | 1 | 2019 | 6 | 0.040 |
Why?
|
Mirizzi Syndrome | 1 | 2019 | 2 | 0.040 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2005 | 2510 | 0.040 |
Why?
|
Colostomy | 1 | 2019 | 107 | 0.040 |
Why?
|
Obesity | 1 | 2021 | 13090 | 0.040 |
Why?
|
Hepatic Encephalopathy | 1 | 2000 | 143 | 0.040 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2009 | 2841 | 0.040 |
Why?
|
Fluoroscopy | 1 | 2023 | 948 | 0.040 |
Why?
|
Hypotension | 2 | 2016 | 887 | 0.040 |
Why?
|
Feasibility Studies | 2 | 2022 | 5306 | 0.040 |
Why?
|
Equipment and Supplies | 1 | 2021 | 273 | 0.040 |
Why?
|
Injections, Intramuscular | 1 | 2019 | 551 | 0.040 |
Why?
|
Abnormalities, Multiple | 1 | 2005 | 1424 | 0.040 |
Why?
|
Software Design | 1 | 2018 | 173 | 0.040 |
Why?
|
Computer Systems | 1 | 2019 | 467 | 0.040 |
Why?
|
Needles | 1 | 2021 | 461 | 0.040 |
Why?
|
Immunohistochemistry | 2 | 2009 | 11062 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13644 | 0.040 |
Why?
|
Body Fluids | 1 | 2019 | 321 | 0.040 |
Why?
|
Body Mass Index | 2 | 2016 | 13050 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2002 | 1733 | 0.040 |
Why?
|
Health Care Rationing | 1 | 2021 | 435 | 0.040 |
Why?
|
Nose | 1 | 2021 | 522 | 0.040 |
Why?
|
Manometry | 1 | 2019 | 458 | 0.040 |
Why?
|
Lasers | 1 | 2021 | 951 | 0.030 |
Why?
|
Artificial Intelligence | 2 | 2022 | 2662 | 0.030 |
Why?
|
Colony Count, Microbial | 1 | 2017 | 326 | 0.030 |
Why?
|
Debridement | 1 | 2019 | 494 | 0.030 |
Why?
|
Proto-Oncogene Proteins | 1 | 2009 | 4523 | 0.030 |
Why?
|
Secondary Prevention | 1 | 2003 | 1469 | 0.030 |
Why?
|
Teaching Rounds | 1 | 2020 | 280 | 0.030 |
Why?
|
Animals | 4 | 2022 | 168939 | 0.030 |
Why?
|
Flumazenil | 1 | 2016 | 84 | 0.030 |
Why?
|
Microbiological Techniques | 1 | 2016 | 97 | 0.030 |
Why?
|
Area Under Curve | 1 | 2020 | 1639 | 0.030 |
Why?
|
Water | 1 | 2022 | 1416 | 0.030 |
Why?
|
Pravastatin | 1 | 2017 | 391 | 0.030 |
Why?
|
Atropine | 1 | 2016 | 243 | 0.030 |
Why?
|
Models, Anatomic | 1 | 2019 | 678 | 0.030 |
Why?
|
Light | 1 | 2021 | 1358 | 0.030 |
Why?
|
Learning Curve | 1 | 2017 | 232 | 0.030 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2019 | 452 | 0.030 |
Why?
|
Fasting | 1 | 2021 | 1609 | 0.030 |
Why?
|
Necrosis | 1 | 2019 | 1614 | 0.030 |
Why?
|
Metals | 1 | 2019 | 711 | 0.030 |
Why?
|
Incidental Findings | 1 | 2019 | 698 | 0.030 |
Why?
|
Prosthesis Implantation | 1 | 2019 | 594 | 0.030 |
Why?
|
Pilot Projects | 2 | 2022 | 8728 | 0.030 |
Why?
|
Internship and Residency | 1 | 2015 | 5943 | 0.030 |
Why?
|
China | 1 | 2020 | 2386 | 0.030 |
Why?
|
Midazolam | 1 | 2016 | 267 | 0.030 |
Why?
|
Mice, Nude | 1 | 2020 | 3618 | 0.030 |
Why?
|
Bradycardia | 1 | 2016 | 304 | 0.030 |
Why?
|
Polysaccharides | 1 | 2020 | 1020 | 0.030 |
Why?
|
Prosthesis Failure | 1 | 2019 | 1208 | 0.030 |
Why?
|
Intestinal Fistula | 1 | 2014 | 146 | 0.030 |
Why?
|
Internationality | 1 | 2019 | 1006 | 0.030 |
Why?
|
Infection Control | 1 | 2021 | 984 | 0.030 |
Why?
|
Quality of Health Care | 1 | 2008 | 4306 | 0.030 |
Why?
|
Naloxone | 1 | 2016 | 372 | 0.030 |
Why?
|
Disease Progression | 3 | 2022 | 13642 | 0.030 |
Why?
|
Tumor Cells, Cultured | 1 | 2020 | 6105 | 0.030 |
Why?
|
Nursing Homes | 1 | 2020 | 1084 | 0.030 |
Why?
|
Anesthesia, Inhalation | 1 | 2013 | 220 | 0.030 |
Why?
|
Fentanyl | 1 | 2016 | 451 | 0.030 |
Why?
|
Digestive System Diseases | 1 | 2014 | 152 | 0.030 |
Why?
|
Comparative Effectiveness Research | 1 | 2017 | 713 | 0.020 |
Why?
|
Workflow | 1 | 2017 | 859 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2020 | 3605 | 0.020 |
Why?
|
ROC Curve | 1 | 2020 | 3621 | 0.020 |
Why?
|
Cardiovascular Diseases | 1 | 2017 | 15652 | 0.020 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2016 | 772 | 0.020 |
Why?
|
Disease Outbreaks | 1 | 2020 | 1761 | 0.020 |
Why?
|
Cross-Over Studies | 1 | 2017 | 2105 | 0.020 |
Why?
|
Fellowships and Scholarships | 1 | 2019 | 1134 | 0.020 |
Why?
|
Lithotripsy | 1 | 2011 | 137 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2003 | 10745 | 0.020 |
Why?
|
Hypercholesterolemia | 1 | 2017 | 1145 | 0.020 |
Why?
|
Anticholesteremic Agents | 1 | 2017 | 970 | 0.020 |
Why?
|
Prescription Drugs | 1 | 2017 | 634 | 0.020 |
Why?
|
Venous Thrombosis | 1 | 2019 | 1321 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2013 | 1587 | 0.020 |
Why?
|
Equipment Safety | 1 | 2010 | 250 | 0.020 |
Why?
|
Registries | 2 | 2019 | 8352 | 0.020 |
Why?
|
Disease Management | 1 | 2019 | 2533 | 0.020 |
Why?
|
Treatment Failure | 1 | 2015 | 2659 | 0.020 |
Why?
|
Combined Modality Therapy | 2 | 2011 | 8540 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2020 | 26309 | 0.020 |
Why?
|
Mortality | 1 | 2019 | 2908 | 0.020 |
Why?
|
Informed Consent | 1 | 2014 | 1010 | 0.020 |
Why?
|
Focus Groups | 1 | 2014 | 1459 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2013 | 1186 | 0.020 |
Why?
|
Video Recording | 1 | 2012 | 977 | 0.020 |
Why?
|
Duodenum | 1 | 2010 | 495 | 0.020 |
Why?
|
Appointments and Schedules | 1 | 2010 | 442 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2020 | 5344 | 0.020 |
Why?
|
Regression Analysis | 1 | 2016 | 6329 | 0.020 |
Why?
|
Gastric Bypass | 1 | 2014 | 820 | 0.020 |
Why?
|
Computer Simulation | 1 | 2019 | 6258 | 0.020 |
Why?
|
Survival Rate | 1 | 2019 | 12826 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2002 | 10384 | 0.020 |
Why?
|
Comorbidity | 1 | 2019 | 10580 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2020 | 10451 | 0.010 |
Why?
|
Boston | 1 | 2017 | 9346 | 0.010 |
Why?
|
Sex Distribution | 1 | 2009 | 2274 | 0.010 |
Why?
|
Apoptosis | 1 | 2020 | 9514 | 0.010 |
Why?
|
Radiotherapy Dosage | 1 | 2011 | 2916 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2009 | 2846 | 0.010 |
Why?
|
DiGeorge Syndrome | 1 | 2005 | 187 | 0.010 |
Why?
|
Age Distribution | 1 | 2009 | 2869 | 0.010 |
Why?
|
Telemedicine | 1 | 2021 | 3111 | 0.010 |
Why?
|
Health Services Accessibility | 1 | 2021 | 5513 | 0.010 |
Why?
|
Movement | 1 | 2010 | 1468 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2014 | 3692 | 0.010 |
Why?
|
Body Weight | 1 | 2013 | 4626 | 0.010 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2011 | 1673 | 0.010 |
Why?
|
Cognition | 1 | 2019 | 7057 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2010 | 6853 | 0.010 |
Why?
|
Psychological Tests | 1 | 2000 | 642 | 0.010 |
Why?
|
Epithelial Cells | 1 | 2009 | 3698 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2009 | 12536 | 0.010 |
Why?
|
Mice | 1 | 2020 | 81898 | 0.010 |
Why?
|
Heart Defects, Congenital | 1 | 2005 | 4712 | 0.000 |
Why?
|
Infant, Newborn | 1 | 2005 | 26387 | 0.000 |
Why?
|
Infant | 1 | 2005 | 36459 | 0.000 |
Why?
|
Child, Preschool | 1 | 2005 | 42577 | 0.000 |
Why?
|
Child | 1 | 2005 | 80670 | 0.000 |
Why?
|